EUVIMEDEUVIMED entdecken
Open Access · CC BY 4.0

The chromosome-level genome of Mesobuthus martensii provides insights into its evolution and the diversity of venom peptides

Daixi Liu, Qianhui Zeng, Yifei Sun, Changfen Li, Yanjun Song, Zhuo Shang, Kunlong Li, Hongjie Zhu, Feng Li, Chuanbin Shen, Jianhua Ju

Pharmaceutical Science Advances · 2026-12 · 4 · 100149

DOI: 10.1016/j.pscia.2026.100149 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Pharmaceutical Science Advances, 2026-12. Verfasst von Daixi Liu und 10 weiteren Autor:innen. Beteiligte Einrichtung: State Key Laboratory of Discovery and Utilization of Functional Components in Traditional Chinese Medicine, Key Laboratory of Chemical Biology (Minis…. Die Arbeit nennt 46 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: National Natural Science Foundation of China.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Mesobuthus martensii, the source species of the traditional Chinese medicine "Quanxie", has long been utilized for its therapeutic properties. Venom peptides are recognized as the major active molecular basis of these pharmacological activities. Despite this, their development as therapeutic agents remains poorly explored. In this study, we performed an integrated multi-omics investigation to systematically explore the venom peptides of Mesobuthus martensii. We generated a chromosome-level genome assembly of Mesobuthus martensii using third-generation sequencing technologies, yielding a genome size of 1.08 Gb with a contig N50 of 46.46 Mb. Integrated genomic and transcriptomic analyses led to the identification of 51 putative novel venom peptide candidates. From the broader venom peptide set, five lysine- and arginine-rich candidates were selected for recombinant expression and functional characterization. Functional evaluation revealed that MmTX67, MmTX106 and MmTX126 modulated coagulation-related parameters in vitro, with MmTX106 further demonstrating the most pronounced antithrombotic effect in vivo. Collectively, these findings provide novel insights into the genetic basis of bioactive substances in "Quanxie" and highlight MmTX106 as the most promising antithrombotic candidate, while providing a molecular foundation for further evaluation of other scorpion venom-derived peptide candidates.

Schlagwörter

Stichwörter der Autor:innen

Antithrombotic peptideChromosome-level genomeMesobuthus martensiiQuanxieVenom peptide

Autor:innen und Institutionen

  • State Key Laboratory of Discovery and Utilization of Functional Components in Traditional Chinese Medicine, Key Laboratory of Chemical Biology (Ministry of Education), Shandong Basic Science Research Center (Pharmacy),…
  • Key Laboratory of Marine Drugs, Chinese Ministry of Education, School of Medicine and Pharmacy, Ocean University of China, Qingdao, 266000, China.

Förderung

  • National Natural Science Foundation of China

Zitieren

APA

Liu, D., Zeng, Q., Sun, Y., Li, C., Song, Y., Shang, Z., Li, K., Zhu, H., Li, F., Shen, C., & Ju, J. (2026). The chromosome-level genome of Mesobuthus martensii provides insights into its evolution and the diversity of venom peptides. Pharmaceutical Science Advances, 4, 100149. https://doi.org/10.1016/j.pscia.2026.100149

Vancouver

Liu D, Zeng Q, Sun Y, Li C, Song Y, Shang Z, et al. The chromosome-level genome of Mesobuthus martensii provides insights into its evolution and the diversity of venom peptides. Pharmaceutical Science Advances. 2026;4:100149. doi:10.1016/j.pscia.2026.100149

BibTeX
@article{Liu2026,
  author = {Liu, Daixi and Zeng, Qianhui and Sun, Yifei and Li, Changfen and Song, Yanjun and Shang, Zhuo and Li, Kunlong and Zhu, Hongjie and Li, Feng and Shen, Chuanbin and Ju, Jianhua},
  title = {The chromosome-level genome of Mesobuthus martensii provides insights into its evolution and the diversity of venom peptides},
  journal = {Pharmaceutical Science Advances},
  year = {2026},
  volume = {4},
  pages = {100149},
  doi = {10.1016/j.pscia.2026.100149}
}
Kostenlos starten →